Cyclophilin inhibitors in hepatitis C viral infection (Q36916858)

17 August 2017

1 reference

title

Cyclophilin inhibitors in hepatitis C viral infection (English)

1 reference

17 August 2017

1 reference

1

Robert Flisiak

1 reference

17 August 2017

Jean-Maurice Dumont

2

1 reference

PubMed ID

17714021

17 August 2017

Raf Crabbé

series ordinal

3

1 reference

PubMed ID

17714021

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Expert Opinion on Investigational Drugs

17 August 2017

1 reference

17 August 2017

16

1 reference

17 August 2017

9

1 reference

17 August 2017

1345-1354

1 reference

HCV natural history: the retrospective and prospective in perspective

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Clinical consequences of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Chronic hepatitis C virus management: 2000-2005 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Unravelling hepatitis C virus replication from genome to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

The culture of designing hepato-biliary randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Specific incorporation of cyclophilin A into HIV-1 virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Dealing with the family: CD147 interactions with cyclophilins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Roles of cyclophilins in cancers and other organ systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Cyclophilin C-associated protein is up-regulated during wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Cyclophilin D as a drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Treating hepatitis C: can you teach old dogs new tricks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Selective inhibitors of hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

A pilot study of the combination of cyclosporin A and interferon alfacon-1 for the treatment of hepatitis C in previous nonresponder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

Structural biology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.9.1345

10.1517/13543784.16.9.1345

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17714021